Description
Composition Bortezomib (2mg)
Primary Use Multiple myeloma, Mantle-cell lymphoma
cautionPotentially unsafe with Lactation
Medicine Overview of BortePlus Injection
Uses of BortePlus Injection
BortePlus 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
BortePlus Injection side effects
Common
Low blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia (low number of red blood cells), Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation.
How to use BortePlus Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How BortePlus Injection works
BortePlus 2mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
In Depth Information on BortePlus Injection
Expert advice for BortePlus Injection
- Before taking bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.
- Drink plenty of fluids every day during your treatment with bortezomib.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
- Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.
- Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.
BortePlus Injection related warnings
Special precautions for BortePlus Injection
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
WEIGH RISKS VS BENEFITS
BortePlus 2mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Lactation
UNSAFE
BortePlus 2mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Driving
Do not drive unless you are feeling well. BortePlus 2mg Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.
Kidney
BortePlus 2mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of BortePlus 2mg Injection may be needed. Please consult your doctor. Limited information is available on the use of BortePlus 2mg Injection in these patients.
Liver
CAUTION
BortePlus 2mg Injection should be used with caution in patients with liver disease. Dose adjustment of BortePlus 2mg Injection may be needed. Please consult your doctor.
What if you miss a dose of BortePlus Injection?
If you miss a dose of BortePlus 2mg Injection, please consult your doctor.
